Get started
PROCTER & GAMBLE HEALTH LIMITEPROCTER & GAMBLE HEALTH LIMITEPROCTER & GAMBLE HEALTH LIMITE

PROCTER & GAMBLE HEALTH LIMITE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

PGHL chart


Full chart

PGHL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪89.59 B‬ INR
Dividend yield (indicated)
2.04%
Price to earnings Ratio (TTM)
41.40
Basic EPS (TTM)
131.15 INR
Net income (FY)
‪2.01 B‬ INR
Revenue (FY)
‪11.51 B‬ INR
Shares float
‪7.94 M‬
Beta (1Y)
0.76

Employees


Employees (FY)
‪1.54 K‬
Change (1Y)
−55 −3.44%
Revenue / Employee (1Y)
‪7.45 M‬ INR
Net income / Employee (1Y)
‪1.30 M‬ INR

About PROCTER & GAMBLE HEALTH L


Sector
Health Technology
CEO
Milind Thatte
Headquarters
Mumbai
Website
pghealthindia.com
Founded
1967
ISIN
INE199A01012
FIGI
BBG000CQR0Z0
Procter & Gamble Health Ltd. engages in the manufacture and marketing of pharmaceuticals products. It offers its products through the following brands: Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. It operates through India, and Outside India geographical segments. The company was founded in 1967 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PGHL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PGHL is 5,397.40 INR — it has decreased by −0.62% in the past 24 hours. Watch PROCTER & GAMBLE HEALTH LIMITE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange PROCTER & GAMBLE HEALTH LIMITE stocks are traded under the ticker PGHL.
PGHL stock has fallen by −4.49% compared to the previous week, the month change is a 4.61% rise, over the last year PROCTER & GAMBLE HEALTH LIMITE has showed a 9.04% increase.
PGHL reached its all-time high on Feb 11, 2021 with the price of 7,499.95 INR, and its all-time low was 260.00 INR and was reached on Oct 27, 2008. View more price dynamics on PGHL chart.
See other stocks reaching their highest and lowest prices.
PGHL stock is 1.27% volatile and has beta coefficient of 0.76. Track PROCTER & GAMBLE HEALTH LIMITE stock price on the chart and check out the list of the most volatile stocks — is PROCTER & GAMBLE HEALTH LIMITE there?
Today PROCTER & GAMBLE HEALTH LIMITE has the market capitalization of ‪89.59 B‬, it has decreased by −1.61% over the last week.
Yes, you can track PROCTER & GAMBLE HEALTH LIMITE financials in yearly and quarterly reports right on TradingView.
PROCTER & GAMBLE HEALTH LIMITE is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
PGHL net income for the last quarter is ‪823.30 M‬ INR, while the quarter before that showed ‪167.80 M‬ INR of net income which accounts for 390.64% change. Track more PROCTER & GAMBLE HEALTH LIMITE financial stats to get the full picture.
PROCTER & GAMBLE HEALTH LIMITE dividend yield was 2.18% in 2024, and payout ratio reached 90.85%. The year before the numbers were 1.81% and 68.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪1.54 K‬ employees. See our rating of the largest employees — is PROCTER & GAMBLE HEALTH LIMITE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROCTER & GAMBLE HEALTH LIMITE EBITDA is ‪3.34 B‬ INR, and current EBITDA margin is 27.08%. See more stats in PROCTER & GAMBLE HEALTH LIMITE financial statements.
Like other stocks, PGHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROCTER & GAMBLE HEALTH LIMITE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROCTER & GAMBLE HEALTH LIMITE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROCTER & GAMBLE HEALTH LIMITE stock shows the strong buy signal. See more of PROCTER & GAMBLE HEALTH LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.